# Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients

> **NCT06051045** · — · RECRUITING · sponsor: **Karolinska University Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Chronic Hepatitis D

## Interventions

- **DRUG:** Bulevirtide

## Key facts

- **NCT ID:** NCT06051045
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-27
- **Primary completion:** 2033-03
- **Final completion:** 2033-03
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06051045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06051045, "Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06051045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*